共 50 条
- [21] ABSORB trial: twelve months results of clinical evaluation of the Bioabsorbable Everolimus-Eluting coronary Stent system in the treatment of patients with de novo native coronary artery lesions AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 36L - 37L
- [25] SPIRIT II clinical study:: A clinical evaluation of the XIENCE™ v Everolimus Eluting Coronary Stent System in the treatment of patients with de novo native coronary artery lesions AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 147M - 147M
- [26] 3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions The SPIRIT II Trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions) JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (12) : 1190 - 1198
- [30] ABSORB Trial: Two Years Clinical and Angiographic Results of Clinical Evaluation of the Bioabsorbable Everolimus-Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 181I - 181I